{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:35:04Z","timestamp":1769798104279,"version":"3.49.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of diffuse large B-cell lymphoma, with nodal involvement being particularly uncommon. Due to its atypical clinical presentation, timely and accurate diagnosis is often challenging. Positron emission tomography\u2013computed tomography (PET-CT) and pathological biopsy can assist in the diagnostic process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>A 52-year-old woman with acquired immune deficiency syndrome (AIDS) and a one-year history of chronic hepatitis B was admitted to the Infection Department of Chongqing Public Medical Center in September 2021. She had been on long-term antiviral therapy with Lamivudine, Tenofovir, and Efavirenz (3TC\/TDF\/EFV). Her chief complaints included a left groin mass, fever, and significant weight loss. Surgical excision and pathological examination of the left inguinal lymph nodes confirmed the diagnosis of IVLBCL. Following effective antiretroviral therapy and six cycles of CHOP\/R-CHOP chemotherapy, the patient achieved complete remission. The patient remained free of lymphoma recurrence during the two-year follow-up; passed away due to COVID-19 in March 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case illustrates four critical teaching points: (1) intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of DLBCL; (2) isolated lymph node involvement is exceptionally uncommon in reported cases; (3) the absence of typical cutaneous or central nervous system involvement further complicates the diagnosis; and (4) its occurrence in an HIV-positive patient represents a particularly unusual clinical scenario. Early recognition of these atypical features, together with prompt combined antiretroviral and chemotherapy, achieved complete remission despite profound immunosuppression, highlighting the need for vigilant and individualized management in such rare and diagnostically challenging presentations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1767472","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:26:12Z","timestamp":1769750772000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Acquired immune deficiency syndrome-related intravascular large B-cell lymphoma primarily arising from lymph nodes: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi sui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Gang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2017.1287363","article-title":"Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database","volume":"58","author":"Rajyaguru","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15091","article-title":"Current progress and future perspectives of research on intravascular large B-cell lymphoma","volume":"10","author":"Shimada","year":"2021","journal-title":"Cancer Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16459","article-title":"Intravascular large B-cell lymphoma: A diagnostic dilemma","volume":"13","author":"Roy","year":"2021","journal-title":"Cureus"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.2514","article-title":"Progressive edemas and generalized telangiectasia: A presentation of Intravascular B-cell Lymphoma","volume":"7","author":"V\u00e1squez","year":"2019","journal-title":"Clin Case Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-021253","article-title":"Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5","volume":"109","author":"Murase","year":"2007","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13000-020-00989-x","article-title":"EBV-positive intravascular large B-cell lymphoma of the liver: a case report and literature review","volume":"15","author":"Li","year":"2020","journal-title":"Diagn Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.09.110","article-title":"Random skin biopsies before brain biopsy for intravascular large B-cell lymphoma","volume":"121","author":"Yamada","year":"2019","journal-title":"World Neurosurg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2021.03.014","article-title":"Virus de l\u2019immunod\u00e9ficience humaine et lymphome [Human immunodeficiency virus and lymphoma","volume":"108","author":"Tazi","year":"2021","journal-title":"Bull Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1298121","DOI":"10.1155\/2022\/1298121","article-title":"Cardiac involvement by human herpesvirus 8-positive diffuse large B-cell lymphoma: an unusual presentation in a patient with human immunodeficiency virus","volume":"2022","author":"Fenu","year":"2022","journal-title":"Case Rep Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.11406\/rinketsu.57.3","article-title":"Pathogenesis and novel therapy for EBV-related B-cell lymphoma","volume":"57","author":"Sato","year":"2016","journal-title":"Rinsho Ketsueki"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/107327481502200315","article-title":"Association of lymphomagenesis and the reactivation of hepatitis B virus in non-hodgkin lymphoma","volume":"22","author":"Dalia","year":"2015","journal-title":"Cancer Control"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i32.11054","article-title":"Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment","volume":"20","author":"Visco","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-791400","article-title":"Optimizing treatment of HIV-associated lymphoma","volume":"134","author":"Noy","year":"2019","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4742","article-title":"Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective study","volume":"11","author":"Bonnet","year":"2022","journal-title":"Cancer Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003452","article-title":"Associations of CD4 cell count measures with infection-related and infection-unrelated cancer risk among people with HIV","volume":"96","author":"Nicolau","year":"2024","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad730","article-title":"Treatment responses to integrase strand-transfer inhibitor-containing antiretroviral regimens in combination with short-course rifapentine-based regimens for latent tuberculosis infection among people with HIV","volume":"78","author":"Lin","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2024-004118","article-title":"Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy","volume":"32","author":"Colominas-Gonz\u00e1lez","year":"2025","journal-title":"Eur J Hosp Pharm"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1767472\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:26:13Z","timestamp":1769750773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1767472\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":18,"alternative-id":["10.3389\/fonc.2026.1767472"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1767472","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"article-number":"1767472"}}